New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim's investigational biologic compound BI 655066*, over ustekinumab.

Body adornment is a human characteristic and has been practiced since ancient times in all races and in all continents.

Lymphedema patients saw a nearly 80 percent reduction in their cellulitis episodes just by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology...

New research suggests the more severe a person's psoriasis is, the more likely they are to have increased blood vessel inflammation - a condition known as vasculitis.

Online advertising may be a feasible way to deliver targeted prevention messages related to indoor tanning and skin cancer, according to an article published online by JAMA Dermatology.

Gay and bisexual men indoor tan more frequently and report higher rates of skin cancer than heterosexual men, according to an article published online by JAMA Dermatology.

The National Institute for Health and Care Excellence (NICE) has today (Wednesday 7 October) said yes to pembrolizumab for treating advanced skin cancer after treatment with ipilimumab in final...

According to the American Cancer Society, more than 70,000 people are diagnosed with melanoma each year in the United States.

Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, has announced approval from the U.S.

A procedure commonly performed in emergency departments on cutaneous abscesses may not have any impact on the need for further interventions and therefore may not be necessary, according to a study...